Skip to main content Back to Top

COVID Updates and the End of PHE: What it Means for You

Broadcast Date: May 14, 2023

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.

SPEAKERS

Katherine YangKatherine Yang, PharmD, MPH, FCSHP is a Health Sciences Clinical Professor of Pharmacy at the University of California, San Francisco (UCSF) School of Pharmacy and an Infectious Diseases Clinical Pharmacist at the UCSF Medical Center in San Francisco, California. Dr. Yang specializes in the optimization of antibiotic dosing for the treatment of multi-drug resistant gram-negative infections. Since the start of the pandemic, Dr. Yang has been heavily involved in the management of COVID-19 therapeutics at UCSF.

Monica MahoneyMonica Mahoney, PharmD, BCPS, BCIDP, FCCP is a clinical pharmacy specialist in the outpatient infectious diseases and OPAT clinics at Beth Israel Deaconess Medical Center. Dr. Mahoney received her Pharm.D. degree from MCPHS University Boston. She completed PGY1 and PGY2-ID residencies at Tufts Medical Center in Boston, Massachusetts. She is an active member of many pharmacy and infectious diseases professional organizations, including ASHP, SIDP, and IDSA.

Michael GanioMichael Ganio, PharmD, MS, BCPS, FASHP joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile drug compounding practices, hazardous drug handling, and the ASHP Standardize 4 Safety initiative. Dr. Ganio earned his Pharm.D. from the Rutgers University Ernest Mario School of Pharmacy and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center. Dr. Ganio is a Board Certified Pharmacotherapy Specialist (BCPS) and is a Certified Professional in Healthcare Information and Management Systems (CPHIMS).

Relevant Financial Relationship Disclosures

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. 

Resources

www.ashp.org/COVID-19

COVID-19 Prevention and Treatment Strategies for the Immunocompromised-Living Handout

More in this Series

New Year, New Subvariants - COVID Therapeutics in 2023

Boosters, Biologics, Antivirals - Oh My! - COVID-19 in the Immunocompromised


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is provided by ASHP and supported by an educational grant from AstraZeneca.